Lactose manufacturer Meggle has announced the launch of InhaLac 500 micronized lactose for dry powder inhalation formulations, saying “Combined with high quality and safety, this material meets the most demanding individual dry powder inhalation formulation requirements.”
According to the company, 90% of the particles in InhaLac 500 are less than 10 µm in size, and the product can be used as a co-agglomerate or as fines at 5-15% in a ternary DPI formulation.
Inhalac 500 is also highly cohesive, making it useful for soft pellet formulations, and has a retest date of 12 months, the company said.
Read the Meggle press release.
